RCG
TARO

Ruggie Capital Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Ruggie Capital Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-250
Closed -$21K – 493
2018
Q4 		$21K Buy
+250
New +$24.1K 0.01% 254

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Ruggie Capital Group's TARO Position: Q1 2019 in Review

Ruggie Capital Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2019, closing a stake of 250 shares — an estimated $21K sold.

Ruggie Capital Group first reported a position in TARO in Q4 2018 and held it in 1 quarter. The position peaked at $21K in Q4 2018. 104 funds tracked by Wall St. Rank hold TARO as of Q1 2019.

  • Ruggie Capital Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 250 Taro Pharmaceutical Industries Ltd. shares in Q1 2019, an estimated $21K.
  • Ruggie Capital Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2018 and held it in 1 quarter.
  • Ruggie Capital Group's Taro Pharmaceutical Industries Ltd. position peaked at $21K in Q4 2018.
  • 104 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2019.

Based on Ruggie Capital Group's 13F filing for Q1 2019, filed 24 Apr 2019.